share_log

We Think China Resources Medical Holdings' (HKG:1515) Healthy Earnings Might Be Conservative

We Think China Resources Medical Holdings' (HKG:1515) Healthy Earnings Might Be Conservative

我們認為華潤醫療控股 (HKG: 1515) 盈利可能保守
Simply Wall St ·  2022/05/03 06:45

Shareholders appeared to be happy with China Resources Medical Holdings Company Limited's (HKG:1515) solid earnings report last week. Looking deeper at the numbers, we found several encouraging factors beyond the headline profit numbers.

股東似乎很滿意 華潤醫療控股有限公司 (HKG: 1515) 上星期盈利報告穩健。更深入地研究這些數字,我們發現了標題利潤數字以外的幾個令人鼓舞的因素。

Check out our latest analysis for China Resources Medical Holdings

查看我們對華潤醫療控股的最新分析

SEHK:1515 Earnings and Revenue History May 2nd 2022
聯交所:1515 年五月二日收益及收入歷史記錄

How Do Unusual Items Influence Profit?

不尋常的項目如何影響利潤?

For anyone who wants to understand China Resources Medical Holdings' profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by CN¥251m due to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. In the twelve months to December 2021, China Resources Medical Holdings had a big unusual items expense. As a result, we can surmise that the unusual items made its statutory profit significantly weaker than it would otherwise be.

對於任何想了解華潤醫療控股利潤超出法定數字的人士,需要注意的是,在過去十二個月內,由於不尋常的項目,法定利潤減少了 CN¥251m。看到花費公司利潤的不尋常項目永遠不會很好,但從好處來看,事情可能會更早而不是晚些時候改善。當我們對全球絕大多數上市公司進行分析時,我們發現大多數不尋常的項目通常不會重複出現。而且,畢竟,這正是會計術語意味著什麼。在截至 2021 年 12 月的十二個月內,華潤醫療控股有一大筆不尋常的項目開支。因此,我們可以推測,這些不尋常的項目使其法定利潤比其他方面明顯減弱。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓您想知道分析師在未來盈利能力方面正在預測哪些內容。幸運的是,您可以單擊此處查看描述未來盈利能力的交互式圖表,根據其估計值。

An Unusual Tax Situation

不尋常的稅收狀況

Having already discussed the impact of the unusual items, we should also note that China Resources Medical Holdings received a tax benefit of CN¥155m. It's always a bit noteworthy when a company is paid by the tax man, rather than paying the tax man. Of course, prima facie it's great to receive a tax benefit. However, the devil in the detail is that these kind of benefits only impact in the year they are booked, and are often one-off in nature. Assuming the tax benefit is not repeated every year, we could see its profitability drop noticeably, all else being equal. While we think it's good that the company has booked a tax benefit, it does mean that there's every chance the statutory profit will come in a lot higher than it would be if the income was adjusted for one-off factors.

在已經討論了不尋常項目的影響之後,我們還應該注意,華潤醫療控股獲得了 150 萬人民幣的稅收優惠。當一家公司由稅務人員支付,而不是支付稅務人員時,總是有點值得注意。當然, 表面表面 獲得稅收優惠真是太好了。但是,細節上的魔鬼在於,這些好處只會在預訂的年份產生影響,並且在本質上通常是一次性的。假設稅收優惠不是每年重複,我們可以看到它的盈利能力明顯下降,其他所有其他都是平等的。雖然我們認為公司已經預訂了稅收優惠是件好事,但這確實意味著法定利潤的每個機會都會比收入根據一次性因素調整收入的情況高得多。

Our Take On China Resources Medical Holdings' Profit Performance

我們對華潤醫療控股利潤表現的看法

In the last year China Resources Medical Holdings received a tax benefit, which boosted its profit in a way that might not be much more sustainable than turning prime farmland into gas fields. Having said that, it also had a unusual item reducing its profit. Based on these factors, we think that China Resources Medical Holdings' profits are a reasonably conservative guide to its underlying profitability. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of China Resources Medical Holdings.

華潤醫療控股在過去一年獲得稅收優惠,其利潤可能不會比將主要農田變成天然氣田更具可持續性。話雖如此,它也有一個不尋常的項目減少了利潤。基於這些因素,我們認為華潤醫療控股的利潤是其潛在盈利能力的合理保守指引。因此,如果您想更深入地研究該股票,則至關重要的是要考慮其面臨的任何風險。例如,我們發現了 1 個警告信號,表明您應該注意一下,以便更好地了解華潤醫療控股。

Our examination of China Resources Medical Holdings has focussed on certain factors that can make its earnings look better than they are. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

我們對華潤醫療控股的考察集中在某些因素上,這些因素可以使其盈利看起來比現時更好。但總是有更多的發現,如果你有能力把你的思想集中在分鐘.有些人認為高股權回報是優質業務的好兆頭。所以大家不妨看看這個 自由 集合擁有高股權回報率的公司, 或這個名單的股票,內部人士正在購買.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?關注內容? 取得聯繫 直接與我們聯繫。 或者,通過電子郵件發送電子郵件給編輯團隊。
這篇文章由簡單牆聖是一般性質. 我們僅使用公正的方法,根據歷史數據和分析師預測提供評論,我們的文章並不打算作為財務建議。 它並不構成購買或出售任何股票的建議,也不會考慮您的目標或您的財務狀況。我們的目標是為您帶來由基本數據驅動的長期集中分析。請注意,我們的分析可能不會考慮最新的價格敏感公司公告或定性材料。簡易華街在提及的任何股票中都沒有倉位。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論